RCUS Arcus Biosciences Inc

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company which focuses on developing and commercializing cancer immunotherapies.

$24.08  -1.24 (-4.88%)
As of 06/28/2022 14:28:37 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/15/2018
Outstanding shares:  71,718,564
Average volume:  940,716
Market cap:   $1,832,409,310
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BDZT9Y9
Valuation   (See tab for details)
PE ratio:   31.61
PB ratio:   2.28
PS ratio:   4.68
Return on equity:   7.21%
Net income %:   14.67%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy